Publications (original articles or review articles) published in 2024 from OUS - Department of Cardiology Ullevaal (Div Med)
26 publications found
[Not Available]
Tidsskr Nor Laegeforen, 144 (2)
DOI 10.4045/tidsskr.23.0849, PubMed 38349090
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572
Effects on physical activity, physical fitness and well-being in a 36-months randomized controlled study, comparing a multimodal hospital-based intervention programme for primary cardiovascular prevention with usual care
BMC Cardiovasc Disord, 24 (1), 225
DOI 10.1186/s12872-024-03892-1, PubMed 38664620
Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
Int J Cardiol, 400, 131809
DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
Atherosclerosis, 393, 117550 (in press)
DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552
Medical Measures in Hypertensives Considered Resistant
Am J Hypertens, 37 (5), 307-317
DOI 10.1093/ajh/hpad118, PubMed 38124494
The Nordic Cardio-Oncology Society: mission and future goals
Eur Heart J (in press)
DOI 10.1093/eurheartj/ehae014, PubMed 38607440
Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
Eur J Prev Cardiol (in press)
DOI 10.1093/eurjpc/zwae086, PubMed 38416125
High Diagnostic Accuracy of Long-Term Electrocardiogram Interpretation by General Practitioners
Int J Telemed Appl, 2024, 6624344
DOI 10.1155/2024/6624344, PubMed 38425473
Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
Eur Heart J Acute Cardiovasc Care, 13 (1), 173-180
DOI 10.1093/ehjacc/zuad158, PubMed 38170562
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Hypertension, 81 (5), 1021-1030
DOI 10.1161/HYPERTENSIONAHA.124.22821, PubMed 38477109
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
J Am Coll Cardiol, 83 (6), 652-664
DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
JACC CardioOncol, 6 (1), 83-95
DOI 10.1016/j.jaccao.2023.10.008, PubMed 38510299
Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
Clin Cardiol, 47 (1), e24216
DOI 10.1002/clc.24216, PubMed 38269628
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891
Gluten-free diet induces rapid changes in phenotype and survival properties of gluten-specific T cells in celiac disease
Gastroenterology (in press)
DOI 10.1053/j.gastro.2024.03.027, PubMed 38552723
De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
Intern Emerg Med (in press)
DOI 10.1007/s11739-024-03590-y, PubMed 38594458
Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment
Mol Biol Rep, 51 (1), 280
DOI 10.1007/s11033-024-09255-5, PubMed 38324186
Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
Eur Heart J Open, 4 (2), oeae011
DOI 10.1093/ehjopen/oeae011, PubMed 38628674
Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
Int J Telemed Appl, 2024, 4080415
DOI 10.1155/2024/4080415, PubMed 38567031
What Is the Current Best Drug Treatment for Hypertensive Heart Failure With Preserved Ejection Fraction? Review of the Totality of Evidence
Am J Hypertens, 37 (1), 1-14
DOI 10.1093/ajh/hpad073, PubMed 37551929
Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Am J Med (in press)
DOI 10.1016/j.amjmed.2024.02.005, PubMed 38387539
The REDUCE-AMI trial: An important step in cardiovascular drug de-prescription
Eur Heart J Acute Cardiovasc Care (in press)
DOI 10.1093/ehjacc/zuae049, PubMed 38608152
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Pharmaceuticals (Basel), 17 (3)
DOI 10.3390/ph17030267, PubMed 38543053
Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
DOI 10.1093/ehjcvp/pvad075, PubMed 37827545
Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
ESC Heart Fail, 11 (2), 871-876
DOI 10.1002/ehf2.14645, PubMed 38204282